News
10 Benefits Of Taking Probiotics
Probiotics are the third-most consumed dietary supplement in the United States. So, what are probiotics, and how do they help your body?
Your body is home to lots of bacteria, not all of which are bad. Some bacteria harm your...
IT & Data Management
Citeline Finalist CluePoints Show Advanced AI Capabilities
CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has announced it has been shortlisted for the 2023 Citeline Awards in the Best Use of Artificial Intelligence in Clinical Trials category.
The...
Drug Research
First Gene Therapy Comes Into Picture For AADC Deficiency
In the final draft guidance rolled out by the National Institute for Health and Care Excellence- NICE, a single-dose therapy, eladocagene exuparvovec, has been recommended for patients who are more than 18 months old and happen to be suffering...
Drug Research
Australia Offers Hope For Drug Resistant Epilepsy Patients
More than 150,000 Australians and 50 million people across the world are affected by epilepsy, with almost one-third finding it challenging to control the condition with the anti-seizure medications that are currently in use. The patients with such drug-resistant...
News
How Does Radiology Impact Healthcare?
Radiology plays a huge role in healthcare today, providing diagnosis and treatment for all kinds of medical issues. It's fascinating to learn how it has developed over time, from its humble origins up to the present-day cutting-edge tools we're...
News
SGD Pharma achieves prestigious gold EcoVadis Sustainability Rating
SGD Pharma, a global leader in glass pharmaceutical packaging, has been rated gold - indicating top 5% performance - following a rigorous sustainability assessment by EcoVadis, the world’s most trusted provider of business sustainability ratings. EcoVadis assesses companies in...
Drug Research
Samsung Biologics announces construction of Plant 5 to commence Bio Campus II capacity expansion
Samsung Biologics, a leading contract development and manufacturing organization (CDMO), announced that the company will commence the construction of a fifth plant as part of its strategic expansion in response to increased market demand.
The company will invest over KRW...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















